Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
9.39
+0.44 (4.92%)
At close: May 12, 2025, 4:00 PM
8.74
-0.65 (-6.92%)
Pre-market: May 13, 2025, 4:00 AM EDT
Niagen Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 55.46 | 44.51 | 27.17 | 20.29 | 28.02 | 16.5 | Upgrade
|
| Cash & Short-Term Investments | 55.46 | 44.51 | 27.17 | 20.29 | 28.02 | 16.5 | Upgrade
|
| Cash Growth | 102.33% | 63.80% | 33.93% | -27.59% | 69.84% | -11.36% | Upgrade
|
| Accounts Receivable | 7.05 | 7.77 | 5.23 | 8.48 | 5.23 | 2.69 | Upgrade
|
| Other Receivables | 0.9 | 0.9 | - | - | - | - | Upgrade
|
| Receivables | 7.95 | 8.67 | 5.23 | 8.48 | 5.23 | 2.69 | Upgrade
|
| Inventory | 11.19 | 9.19 | 14.53 | 14.68 | 13.6 | 11.68 | Upgrade
|
| Prepaid Expenses | 1.47 | 1.58 | 2.45 | 2.97 | 1.86 | 1.15 | Upgrade
|
| Restricted Cash | 0.15 | 0.15 | 0.15 | 0.15 | 0.2 | 0.2 | Upgrade
|
| Total Current Assets | 76.22 | 64.1 | 49.53 | 46.57 | 48.91 | 32.22 | Upgrade
|
| Property, Plant & Equipment | 4.34 | 3.45 | 4.54 | 6.32 | 7.36 | 4.43 | Upgrade
|
| Other Intangible Assets | 0.32 | 0.36 | 0.51 | 0.67 | 0.86 | 1.08 | Upgrade
|
| Other Long-Term Assets | 0.46 | 0.37 | 0.38 | 0.5 | 0.72 | 0.63 | Upgrade
|
| Total Assets | 81.34 | 68.28 | 54.96 | 54.06 | 57.84 | 38.36 | Upgrade
|
| Accounts Payable | 10.63 | 8.53 | 10.23 | 9.68 | 10.42 | 9.45 | Upgrade
|
| Accrued Expenses | 9.05 | 7.82 | 9.49 | 7.34 | 6.48 | 6.13 | Upgrade
|
| Current Portion of Leases | 0.95 | 0.99 | 0.7 | 0.7 | 0.55 | 0.62 | Upgrade
|
| Current Unearned Revenue | 0.21 | 0.61 | 0.2 | 0.16 | 0.16 | 0.28 | Upgrade
|
| Total Current Liabilities | 20.84 | 17.95 | 20.62 | 17.87 | 17.61 | 16.48 | Upgrade
|
| Long-Term Leases | 2.58 | 1.66 | 2.58 | 3.56 | 4.15 | 1.02 | Upgrade
|
| Long-Term Unearned Revenue | 2.58 | 2.58 | 3.31 | 3.96 | 4.35 | 4.44 | Upgrade
|
| Total Liabilities | 25.99 | 22.18 | 26.51 | 25.39 | 26.11 | 21.93 | Upgrade
|
| Common Stock | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 232.12 | 227.93 | 218.85 | 214.09 | 200.61 | 158.19 | Upgrade
|
| Retained Earnings | -176.85 | -181.91 | -190.46 | -185.49 | -168.95 | -141.83 | Upgrade
|
| Comprehensive Income & Other | -0.01 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Shareholders' Equity | 55.35 | 46.09 | 28.46 | 28.67 | 31.73 | 16.42 | Upgrade
|
| Total Liabilities & Equity | 81.34 | 68.28 | 54.96 | 54.06 | 57.84 | 38.36 | Upgrade
|
| Total Debt | 3.52 | 2.65 | 3.28 | 4.26 | 4.7 | 1.64 | Upgrade
|
| Net Cash (Debt) | 51.94 | 41.86 | 23.9 | 16.03 | 23.32 | 14.86 | Upgrade
|
| Net Cash Growth | 114.74% | 75.16% | 49.05% | -31.24% | 56.91% | -12.04% | Upgrade
|
| Net Cash Per Share | 0.65 | 0.54 | 0.32 | 0.23 | 0.35 | 0.24 | Upgrade
|
| Filing Date Shares Outstanding | 78.94 | 77.92 | 75.48 | 75.02 | 68.49 | 66.92 | Upgrade
|
| Total Common Shares Outstanding | 78.6 | 77.5 | 75.15 | 74.75 | 68.31 | 62.06 | Upgrade
|
| Working Capital | 55.38 | 46.15 | 28.91 | 28.7 | 31.29 | 15.74 | Upgrade
|
| Book Value Per Share | 0.70 | 0.59 | 0.38 | 0.38 | 0.46 | 0.26 | Upgrade
|
| Tangible Book Value | 55.02 | 45.74 | 27.95 | 28 | 30.87 | 15.34 | Upgrade
|
| Tangible Book Value Per Share | 0.70 | 0.59 | 0.37 | 0.37 | 0.45 | 0.25 | Upgrade
|
| Machinery | - | 3.97 | 4.26 | 4.05 | 4.3 | 3.92 | Upgrade
|
| Construction In Progress | - | 0.09 | 0.01 | 0.17 | 0.09 | 0 | Upgrade
|
| Leasehold Improvements | - | 2.21 | 2.15 | 2.06 | 2.39 | 2.36 | Upgrade
|
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.